Tumor Suppressor Gene

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Tumor suppressor gene

A tumor suppressor gene, or antioncogene, is a gene


that protects a cell from one step on the path to cancer. When this gene mutates to cause a loss or reduction in its function, the cell can progress to cancer, usually in combination with other genetic changes. The loss
of these genes may be even more important than protooncogene/oncogene activation for the formation of many
kinds of human cancer cells.[1] Tumor suppressor genes
can be grouped into categories including caretaker genes,
gatekeeper genes, and landscaper genes; the classication schemes are evolving as medicine advances, learning from elds including molecular biology, genetics, and
epigenetics.

(C)

Knudson two-hit model


(tumour suppressor gene)
high

disease severity

medium

cancer
susceptibility
state

2nd mutation

medium

2 Functions

50%
(1 allele)

100%
(2 alleles)

0%
(0 allele)

expression level
(B)

50%
(1 allele)

100%
(2 alleles)

expression level
(D)

Haploinsuciency model
(tumour suppressor gene)
high

2nd mutation
medium

Dose responsive model


(oncogene)

disease severity

disease severity

Tumor-suppressor genes, or more precisely, the proteins


they code for, either have a dampening or repressive
eect on the regulation of the cell cycle or promote
apoptosis, and sometimes do both. The functions of
tumor-suppressor proteins fall into several categories including the following:[5]

no disease

0%
(0 allele)

medium

Dose responsive model


(tumour suppressor gene)

1st mutation

no disease

high

Other tumor-suppressor genes that are exceptions to the


two-hit rule are those that exhibit haploinsuciency,
including PTCH in medulloblastoma and NF1 in
neurobroma. An example of this is the p27Kip1 cellcycle inhibitor, in which mutation of a single allele causes
increased carcinogen susceptibility.[4]

Two-hit hypothesis
(A)

high

There are exceptions to the two-hit rule for tumor suppressors, such as certain mutations in the p53 gene product. p53 mutations can function as a dominant negative,
meaning that a mutated p53 protein can prevent the function of normal protein from the un-mutated allele.[3]

disease severity

netics, implying that two independent genetic events were


necessary. He recognized that this was consistent with
a recessive mutation involving a single gene, but requiring biallelic mutation. Oncogene mutations, in contrast,
generally involve a single allele because they are gain-offunction mutations.

1. Repression of genes that are essential for the continuing of the cell cycle. If these genes are not
expressed, the cell cycle does not continue, eectively inhibiting cell division.

1st mutation
no disease

no disease

0%
(0 allele)

50%
(1 allele)

100%
(2 alleles)

expression level
discrete model

100%
(2 alleles)

150%
(3 alleles)

2. Coupling the cell cycle to DNA damage. As long


as there is damaged DNA in the cell, it should not
divide. If the damage can be repaired, the cell cycle
can continue.

200%
(4 alleles)

expression level
continuum model

Models of tumour suppression

3. If the damage cannot be repaired, the cell should initiate apoptosis (programmed cell death) to remove
the threat it poses for the greater good of the organisms produced

Unlike oncogenes, tumor suppressor genes generally follow the "two-hit hypothesis, which implies that both alleles that code for a particular protein must be aected
before an eect is manifested. This is because if only one
allele for the gene is damaged, the second can still produce the correct protein. In other words, mutant tumor
suppressors alleles are usually recessive whereas mutant
oncogene alleles are typically dominant.

4. Some proteins involved in cell adhesion prevent tumor cells from dispersing, block loss of contact inhibition, and inhibit metastasis. These proteins are
known as metastasis suppressors.[6][7]

The two-hit hypothesis was rst proposed by A.G. Knudson for cases of retinoblastoma.[2] Knudson observed that
the age of onset of retinoblastoma followed 2nd order ki-

5. DNA repair proteins are usually classied as tumor


suppressors as well, as mutations in their genes increase the risk of cancer, for example mutations
1

EXTERNAL LINKS

in HNPCC, MEN1 and BRCA. Furthermore, increased mutation rate from decreased DNA repair
leads to increased inactivation of other tumor suppressors and activation of oncogenes.[8]

[2] Knudson AG (1971). Mutation and Cancer: Statistical Study of Retinoblastoma. Proc Natl Acad of Sci 68
(4): 8203. doi:10.1073/pnas.68.4.820. PMC 389051.
PMID 5279523.

Examples

[3] Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (4971):
9125. doi:10.1126/science.2144057. PMID 2144057.

The rst tumor-suppressor protein discovered was the


Retinoblastoma protein (pRb) in human retinoblastoma;
however, recent evidence has also implicated pRb as a
tumor-survival factor.

[4] Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ


(1998). The murine gene p27Kip1 is haplo-insucient
for tumour suppression. Nature 396 (6707): 17780.
doi:10.1038/24179. PMID 9823898.

Another important tumor suppressor is the p53 tumorsuppressor protein encoded by the TP53 gene. Homozygous loss of p53 is found in 65% of colon cancers, 3050% of breast cancers, and 50% of lung cancers. Mutated p53 is also involved in the pathophysiology of leukemias, lymphomas, sarcomas, and neurogenic
tumors. Abnormalities of the p53 gene can be inherited
in Li-Fraumeni syndrome (LFS), which increases the risk
of developing various types of cancers.

[5] Sherr CJ (January 2004). Principles of tumor suppression. Cell 116 (2): 23546. doi:10.1016/S00928674(03)01075-4. PMID 14744434.

PTEN acts by opposing the action of PI3K, which is essential for anti-apoptotic, pro-tumorogenic Akt activation.
As costs of DNA sequencing have diminished, many cancers have now been sequenced for the rst time, revealing novel tumor suppressors. Among the most frequently
mutated genes are components of the SWI/SNF chromatin remodeling complex, which are lost in about 20%
of tumors.[9]
Other examples of tumor suppressors include pVHL,
APC, CD95, ST5, YPEL3, ST7, and ST14.

See also
Metastasis suppressor
Adenomatosis polyposis coli
Oncogene
Cancer
DNA repair
Signal transduction
Von Hippel Lindau Binding protein 1
BRCA1
p53

References

[1] Weinberg, Robert A (2014). The Biology of Cancer.


Garland Science, page 231.

[6] Yoshida BA, Sokolo MM, Welch DR, RinkerSchaeer CW (November 2000). Metastasis-suppressor
genes: a review and perspective on an emerging
eld. J. Natl. Cancer Inst. 92 (21): 171730.
doi:10.1093/jnci/92.21.1717. PMID 11058615.
[7] Hirohashi S, Kanai Y (2003). Cell adhesion system and
human cancer morphogenesis. Cancer Sci 94 (7): 575
81. doi:10.1111/j.1349-7006.2003.tb01485.x. PMID
12841864.
[8] Markowitz S (November 2000). DNA repair defects inactivate tumor suppressor genes and induce hereditary and
sporadic colon cancers. J. Clin. Oncol. 18 (21 Suppl):
75S80S. PMID 11060332.
[9] Shain, AH; Pollack, JR (2013).
The spectrum of SWI/SNF mutations, ubiquitous in human cancers..
PLoS ONE 8 (1):
e55119.
doi:10.1371/journal.pone.0055119.
PMC 3552954.
PMID 23355908.

6 External links
TCF21 gene discovery at Ohio State University
Drosophila Oncogenes and Tumor Suppressors The Interactive Fly
Online book: Tumor Suppressor Genes, published
in 2012
Tumor Suppressor Gene Database, published in
2012

Text and image sources, contributors, and licenses

7.1

Text

Tumor suppressor gene Source: http://en.wikipedia.org/wiki/Tumor%20suppressor%20gene?oldid=630249842 Contributors: Magnus


Manske, Zocky, JWSchmidt, Big Bob the Finder, Furrykef, Samsara, Robbot, Jfdwol, Shibboleth, Zy26, Mdonken, Brim, Arcadian,
RyanGerbil10, Carcharoth, EnSamulili, Palica, Rjwilmsi, FlaBot, Eric4, Mfero, Escheel, SmackBot, Delldot, Darth Panda, Jaganath,
Anand Karia, Davemcarlson, Serephine, UncleDouggie, Gogo Dodo, Tawkerbot4, Chrislk02, Pustelnik, Thijs!bot, Faigl.ladislav, Fluxbot,
TimVickers, Qwerty Binary, Probios, Tedickey, DWeissman, Ohwell32, Nbauman, Boghog, NerdyNSK, Rod57, Dr d12, Mikael Hggstrm, Hchoe, AlnoktaBOT, Philip Trueman, TXiKiBoT, ZPete, Adeez, SieBot, BotMultichill, Forluvoft, AnteaterZot, Osm agha, Aqua
lem, Alexbot, BobKawanaka, BOTarate, DumZiBoT, Addbot, Salwateama2008, DOI bot, Quercus solaris, Arbitrarily0, Legobot, Medsta,
Luckas-bot, Ptbotgourou, Materialscientist, Citation bot, Xqbot, Mononomic, GrouchoBot, Frankie0607, RibotBOT, Srr712, Lycaon83,
FrescoBot, BenzolBot, Citation bot 1, Abductive, Genypholy, Amkilpatrick, Brodyt66, Wikipelli, Jaydiem, Jbergste, ClueBot NG, Jack
Greenmaven, Oramg, Cheater no1, Maadikhah, MerlIwBot, Sergeymukhin, IluvatarBot, , Dontrunwiththosescissors, Phupe1, CancerBioGuru, Pierce568, Monkbot and Anonymous: 70

7.2

Images

File:Models_of_tumour_suppression.svg Source:
http://upload.wikimedia.org/wikipedia/commons/a/a3/Models_of_tumour_
suppression.svg License: CC BY-SA 3.0 Contributors: Emmanuel Barillot, Laurence Calzone, Philippe Hup, Jean-Philippe Vert, Andrei
Zinovyev, Computational Systems Biology of Cancer Chapman & Hall/CRC Mathematical & Computational Biology , 2012 Original
artist: Philippe Hup

7.3

Content license

Creative Commons Attribution-Share Alike 3.0

You might also like